A Delluc1, D Antic2, R Lecumberri3, C Ay4, G Meyer5, M Carrier6. 1. EA 3878, Department of Internal Medicine and Chest Diseases, Centre hospitalier universitaire de Brest, Hôpital de la Cavale Blanche, Brest, France. 2. Clinic for Hematology, Lymphoma Center, Clinical Center Serbia, Medical Faculty, Department for Internal Medicine, University of Belgrade, Belgrade, Serbia. 3. Hematology Service, Clínica Universidad de Navarra, Pamplona, Spain. 4. Department of Medicine I, Clinical Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria. 5. Department of Respiratory Disease, Hôpital Européen Georges Pompidou, Université Paris Descartes, Sorbonne Paris Cité, INSERM UMRS 970 and CIC 1418, Paris, France. 6. Department of Medicine, The Ottawa Hospital Research Institute, University of Ottawa, Ottawa, Ontario, Canada.
Authors: Frits I Mulder; Marc Carrier; Frederiek van Doormaal; Philippe Robin; Hans-Martin Otten; Pierre-Yves Salaun; Harry R Büller; Grégoire Le Gal; Nick van Es Journal: J Thromb Haemost Date: 2020-08-04 Impact factor: 5.824